Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
FG, fasting plasma glucose level
In the Phase 3 trials, lixisenatide (20 g) was administered once daily and showed effectiveness as monotherapy when used in combination with oral antidiabetic medications and as an add-on to basal insulin
Weight loss: Usually 2-5 pounds, primarily water weight and initial fat loss
Buyers must be qualified personnel and agree to use this product in compliance with all applicable laws and regulations
LC-MS or mass-spectrometry documentation supports identity confirmation and molecular-mass review [10][11]
US$ 23.11
US$ 23.53
US$ 24.31
US$ 21.01
US$ 20.10
